Largest Biotechnology Companies by Market Cap
Largest Biotechnology companies by market cap. The Biotechnology sector has 1,295 publicly listed stocks with a combined market cap of $2.06 Trillion. Vertex Pharmaceuticals Inc leads the sector with a market cap of $130.90 Billion. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
Companies Listed
Largest Company
Top Biotechnology Stocks by Market Capitalization (October 2026)
Top Biotechnology stocks by market capitalization as of October 2026, covering 1,295 publicly listed companies.
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1 |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX |
$130.90 Billion | $130.90 Billion | USA | $540.00 | +1.95% | +2.95% | 29.31 Million |
| 2 |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN |
$76.14 Billion | $76.14 Billion | USA | $818.77 | +0.68% | +1.63% | 16.37 Million |
| 3 |
CSL Ltd
AU:CSL |
$67.80 Billion | AU$95.82 Billion | Australia | AU$197.50 | +0.20% | +0.72% | 24.17 Million |
| 4 |
Moderna Inc
NASDAQ:MRNA |
$54.14 Billion | $54.14 Billion | USA | $222.76 | +4.01% | -9.38% | 454.33 Million |
| 5 |
Argen-X
BR:ARGX |
$47.46 Billion | €40.60 Billion | Belgium | €804.40 | +0.98% | +2.26% | 2.44 Million |
| 6 |
argenx NV ADR
NASDAQ:ARGX |
$45.97 Billion | $45.97 Billion | USA | $787.95 | -0.66% | -6.29% | 7.48 Million |
| 7 |
UCB S.A. UNSP.ADR 1/2
F:UNC0 |
$44.84 Billion | €38.35 Billion | Germany | €120.00 | -2.44% | -11.11% | 1.13K |
| 8 |
Samsung Biologics Co Ltd
KO:207940 |
$42.85 Billion | ₩63.23 Trillion | Korea | ₩1366000.00 | -0.44% | -3.60% | 1.67 Million |
| 9 |
Argen-X
F:1AE |
$41.67 Billion | €35.64 Billion | Germany | €798.20 | +2.91% | +7.95% | 415.00 |
| 10 |
Revolution Medicines Inc
NASDAQ:RVMD |
$40.32 Billion | $40.32 Billion | USA | $190.27 | +0.82% | -2.06% | 46.76 Million |
| 11 |
CSL LTD SPON.ADR 2
F:CSJA |
$40.06 Billion | €34.26 Billion | Germany | €18.20 | -3.19% | -9.90% | 420.00 |
| 12 |
UCB SA
BR:UCB |
$38.48 Billion | €32.91 Billion | Belgium | €280.00 | +3.51% | +31.46% | 7.56 Million |
| 13 |
Genmab A/S
CO:GMAB |
$36.51 Billion | Dkr233.34 Billion | Denmark | Dkr3788.00 | -2.07% | +44.58% | 4.82 Million |
| 14 |
BeiGene, Ltd.
NASDAQ:ONC |
$32.38 Billion | $32.38 Billion | USA | $371.56 | -0.48% | -3.86% | 8.45 Million |
| 15 |
Celltrion Inc
KO:068270 |
$29.42 Billion | ₩43.41 Trillion | Korea | ₩189300.00 | -0.26% | -4.20% | 11.02 Million |
| 16 |
Royalty Pharma Plc
NASDAQ:RPRX |
$29.23 Billion | $29.23 Billion | USA | $65.93 | +1.71% | +6.08% | 72.44 Million |
| 17 |
BeiGene Ltd.
F:49B |
$25.73 Billion | €22.01 Billion | Germany | €17.34 | +0.00% | +0.00% | 0.00 |
| 18 |
Insmed Inc
NASDAQ:INSM |
$23.80 Billion | $23.80 Billion | USA | $111.59 | +15.06% | +18.66% | 82.56 Million |
| 19 |
Incyte Corporation
NASDAQ:INCY |
$23.68 Billion | $23.68 Billion | USA | $116.80 | -0.06% | +2.96% | 44.06 Million |
| 20 |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY |
$23.08 Billion | $23.08 Billion | USA | $174.00 | -25.13% | -22.70% | 42.70 Million |
| 21 |
Roivant Sciences Ltd
NASDAQ:ROIV |
$20.44 Billion | $20.44 Billion | USA | $37.52 | +1.10% | +1.96% | 153.84 Million |
| 22 |
BioNTech SE
F:22UA |
$20.05 Billion | €17.15 Billion | Germany | €77.90 | +0.58% | -3.41% | 46.95K |
| 23 |
Innovent Biologics Inc
F:6IB |
$17.98 Billion | €15.38 Billion | Germany | €9.16 | -0.61% | -8.49% | 1.04K |
| 24 |
Genmab AS
NASDAQ:GMAB |
$16.23 Billion | $16.23 Billion | USA | $56.49 | -1.40% | +42.76% | 146.64 Million |
| 25 |
GENMAB AS SP.ADR/1/10DK 1
F:GE91 |
$15.06 Billion | €12.88 Billion | Germany | €23.80 | +3.48% | -2.46% | 68.00 |
| 26 |
WUXI BIOLOGICS UNSP.ADR/2
F:1FW1 |
$14.75 Billion | €12.62 Billion | Germany | €7.20 | -2.04% | -9.43% | 42.00K |
| 27 |
Ascendis Pharma AS
NASDAQ:ASND |
$14.74 Billion | $14.74 Billion | USA | $253.00 | +1.38% | +5.90% | 17.28 Million |
| 28 |
WUXI BIOLOGICS-00000083
F:1FW2 |
$14.60 Billion | €12.49 Billion | Germany | €5.22 | -0.38% | -6.12% | 25.90K |
| 29 |
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ |
$13.04 Billion | $13.04 Billion | USA | $207.83 | +1.35% | -1.95% | 19.24 Million |
| 30 |
Summit Therapeutics PLC
NASDAQ:SMMT |
$12.92 Billion | $12.92 Billion | USA | $16.20 | +2.73% | +2.34% | 156.20 Million |
| 31 |
BridgeBio Pharma Inc
NASDAQ:BBIO |
$12.71 Billion | $12.71 Billion | USA | $70.73 | -0.13% | +4.41% | 65.82 Million |
| 32 |
Ascendis Pharma AS
F:A71 |
$12.65 Billion | €10.82 Billion | Germany | €206.00 | +0.98% | +4.04% | 166.00 |
| 33 |
Exelixis Inc
NASDAQ:EXEL |
$12.17 Billion | $12.17 Billion | USA | $66.20 | -0.12% | +2.51% | 53.02 Million |
| 34 |
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL |
$11.90 Billion | $11.90 Billion | USA | $518.74 | -1.97% | +0.03% | 8.60 Million |
| 35 |
Jazz Pharmaceuticals plc
F:J7Z |
$11.86 Billion | €10.14 Billion | Germany | €185.70 | +1.34% | -1.20% | 69.00 |
| 36 |
Bio-Techne Corp
NASDAQ:TECH |
$11.33 Billion | $11.33 Billion | USA | $72.71 | +0.03% | +0.10% | 67.42 Million |
| 37 |
Avidity Biosciences, Inc
NASDAQ:RNAM |
$11.02 Billion | $11.02 Billion | USA | $71.34 | +0.00% | +0.00% | 0.00 |
| 38 |
Biomarin Pharmaceutical Inc
NASDAQ:BMRN |
$10.63 Billion | $10.63 Billion | USA | $57.49 | +2.66% | +4.13% | 58.45 Million |
| 39 |
ALTEOGEN Inc
KQ:196170 |
$10.37 Billion | ₩15.30 Trillion | Korea | ₩220000.00 | -1.35% | -8.33% | 6.89 Million |
| 40 |
AKESO INC. O.N.
F:4RY |
$10.23 Billion | €8.75 Billion | Germany | €9.50 | -2.06% | -7.98% | 13.92K |
| 41 |
Xizang Haisco Pharmaceutical Group Co Ltd
SHE:002653 |
$9.67 Billion | CN¥66.11 Billion | China | CN¥57.95 | +0.35% | -3.90% | 100.63 Million |
| 42 |
Krystal Biotech Inc
NASDAQ:KRYS |
$9.61 Billion | $9.61 Billion | USA | $324.55 | +0.97% | +0.74% | 6.38 Million |
| 43 |
Vaxcyte Inc
NASDAQ:PCVX |
$9.32 Billion | $9.32 Billion | USA | $62.61 | +1.87% | -0.98% | 86.23 Million |
| 44 |
Nuvalent Inc
NASDAQ:NUVL |
$9.12 Billion | $9.12 Billion | USA | $123.96 | +0.00% | +0.13% | 54.40 Million |
| 45 |
Verona Pharma plc
F:I9SA |
$9.07 Billion | €7.76 Billion | Germany | €90.20 | +0.00% | +0.00% | 47.00 |
| 46 |
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX |
$9.01 Billion | $9.01 Billion | USA | $84.95 | +0.00% | +0.20% | 55.12 Million |
| 47 |
Kymera Therapeutics Inc
NASDAQ:KYMR |
$8.99 Billion | $8.99 Billion | USA | $122.60 | +0.07% | +8.85% | 19.73 Million |
| 48 |
Halozyme Therapeutics Inc
NASDAQ:HALO |
$8.70 Billion | $8.70 Billion | USA | $131.18 | +0.88% | +5.09% | 52.82 Million |
| 49 |
Pharmaron Beijing Co Ltd
SHE:300759 |
$8.64 Billion | CN¥59.07 Billion | China | CN¥40.00 | +1.01% | +3.36% | 974.73 Million |
| 50 |
Cytokinetics Inc
NASDAQ:CYTK |
$8.62 Billion | $8.62 Billion | USA | $63.31 | +3.31% | +0.72% | 44.74 Million |
| 51 |
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR |
$8.43 Billion | $8.43 Billion | USA | $60.49 | +0.47% | +2.80% | 43.20 Million |
| 52 |
Apogee Therapeutics, Inc. Common Stock
NASDAQ:APGE |
$8.40 Billion | $8.40 Billion | USA | $135.07 | -0.01% | +0.16% | 34.02 Million |
| 53 |
TG Therapeutics Inc
NASDAQ:TGTX |
$8.37 Billion | $8.37 Billion | USA | $58.08 | +1.18% | +9.17% | 36.49 Million |
| 54 |
Blueprint Medicines Corp
NASDAQ:BPMC |
$8.36 Billion | $8.36 Billion | USA | $129.46 | +0.00% | +0.00% | 2.98 Million |
| 55 |
Abivax SA
PA:ABVX |
$8.27 Billion | €7.08 Billion | France | €81.10 | +0.43% | -3.85% | 2.56 Million |
| 56 |
Twist Bioscience Corp
NASDAQ:TWST |
$8.26 Billion | $8.26 Billion | USA | $173.45 | +0.00% | +16.31% | 69.20 Million |
| 57 |
Praxis Precision Medicines Inc
NASDAQ:PRAX |
$8.05 Billion | $8.05 Billion | USA | $288.62 | +1.10% | +12.54% | 12.02 Million |
| 58 |
Spyre Therapeutics Inc.
NASDAQ:SYRE |
$7.87 Billion | $7.87 Billion | USA | $98.96 | -0.79% | +6.47% | 32.69 Million |
| 59 |
Tubize-Fin
BR:TUB |
$7.82 Billion | €6.69 Billion | Belgium | €227.60 | +3.08% | +26.16% | 581.76K |
| 60 |
Abivax SA American Depositary Shares
NASDAQ:ABVX |
$7.77 Billion | $7.77 Billion | USA | $89.06 | -0.87% | -4.74% | 26.43 Million |
| 61 |
Caris Life Sciences, Inc. Common Stock
NASDAQ:CAI |
$7.77 Billion | $7.77 Billion | USA | $36.14 | +1.95% | +11.72% | 86.28 Million |
| 62 |
ALK-Abelló A/S
CO:ALK-B |
$7.77 Billion | Dkr49.64 Billion | Denmark | Dkr246.60 | +1.23% | +1.65% | 5.87 Million |
| 63 |
Axsome Therapeutics Inc
NASDAQ:AXSM |
$7.51 Billion | $7.51 Billion | USA | $143.45 | -0.04% | -8.23% | 22.35 Million |
| 64 |
Ionis Pharmaceuticals Inc
NASDAQ:IONS |
$7.38 Billion | $7.38 Billion | USA | $44.39 | -1.14% | +0.27% | 60.96 Million |
| 65 |
Verona Pharma PLC ADR
NASDAQ:VRNA |
$7.31 Billion | $7.31 Billion | USA | $86.00 | +0.00% | -2.27% | 31.77 Million |
| 66 |
Cidara Therapeutics Inc
NASDAQ:CDTX |
$6.96 Billion | $6.96 Billion | USA | $221.38 | +0.03% | +0.26% | 24.25 Million |
| 67 |
Merus BV
NASDAQ:MRUS |
$6.83 Billion | $6.83 Billion | USA | $90.00 | -7.14% | -7.02% | 27.33 Million |
| 68 |
Arcellx Inc
NASDAQ:ACLX |
$6.73 Billion | $6.73 Billion | USA | $115.07 | +0.00% | +0.06% | 44.08 Million |
| 69 |
Asymchem Laboratories Tian Jin Co Ltd
SHE:002821 |
$6.54 Billion | CN¥44.68 Billion | China | CN¥134.21 | -1.50% | -11.84% | 187.94 Million |
| 70 |
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND |
$6.36 Billion | $6.36 Billion | USA | $317.33 | -0.45% | +0.81% | 6.06 Million |
| 71 |
Belite Bio Inc ADR
NASDAQ:BLTE |
$6.17 Billion | $6.17 Billion | USA | $164.45 | -1.77% | -2.55% | 3.65 Million |
| 72 |
Immunovant Inc
NASDAQ:IMVT |
$6.12 Billion | $6.12 Billion | USA | $29.64 | +0.75% | +4.44% | 33.09 Million |
| 73 |
Centessa Pharmaceuticals PLC ADR
NASDAQ:CNTA |
$6.10 Billion | $6.10 Billion | USA | $39.43 | -0.10% | -0.45% | 113.44 Million |
| 74 |
Immunitybio Inc
NASDAQ:IBRX |
$5.96 Billion | $5.96 Billion | USA | $8.74 | -0.79% | +1.16% | 356.52 Million |
| 75 |
Kodiak Sciences Inc
NASDAQ:KOD |
$5.92 Billion | $5.92 Billion | USA | $100.40 | +3.46% | +14.46% | 80.78 Million |
| 76 |
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM |
$5.84 Billion | $5.84 Billion | USA | $93.07 | +1.20% | +5.02% | 16.30 Million |
| 77 |
Corcept Therapeutics Incorporated
NASDAQ:CORT |
$5.61 Billion | $5.61 Billion | USA | $85.95 | -0.38% | -26.08% | 21.97 Million |
| 78 |
Shanghai Allist Pharmaceuticals Co. Ltd. A
SHG:688578 |
$5.47 Billion | CN¥37.36 Billion | China | CN¥83.03 | +2.14% | -1.79% | 211.35 Million |
| 79 |
Bachem Holding AG
SW:BANB |
$5.42 Billion | CHF4.29 Billion | Switzerland | CHF84.35 | +0.36% | +0.24% | 2.08 Million |
| 80 |
CG Oncology, Inc. Common stock
NASDAQ:CGON |
$5.36 Billion | $5.36 Billion | USA | $63.47 | -0.77% | +1.98% | 22.67 Million |
| 81 |
PTC Therapeutics Inc
NASDAQ:PTCT |
$5.35 Billion | $5.35 Billion | USA | $64.46 | +2.28% | +2.94% | 25.10 Million |
| 82 |
Mirum Pharmaceuticals Inc
NASDAQ:MIRM |
$5.27 Billion | $5.27 Billion | USA | $86.39 | +0.68% | +3.54% | 18.53 Million |
| 83 |
Erasca Inc
NASDAQ:ERAS |
$5.24 Billion | $5.24 Billion | USA | $14.98 | -0.93% | +3.38% | 119.37 Million |
| 84 |
Crispr Therapeutics AG
NASDAQ:CRSP |
$5.23 Billion | $5.23 Billion | USA | $54.26 | +0.28% | +7.45% | 35.50 Million |
| 85 |
Cogent Biosciences Inc
NASDAQ:COGT |
$5.19 Billion | $5.19 Billion | USA | $31.96 | -0.84% | +1.69% | 50.46 Million |
| 86 |
Oruka Therapeutics, Inc.
NASDAQ:ORKA |
$5.12 Billion | $5.12 Billion | USA | $96.65 | +0.71% | +20.93% | 22.90 Million |
| 87 |
Definium Therapeutics, Inc.
NASDAQ:DFTX |
$5.10 Billion | $5.10 Billion | USA | $37.96 | -0.37% | +6.96% | 47.95 Million |
| 88 |
Protagonist Therapeutics Inc
NASDAQ:PTGX |
$5.09 Billion | $5.09 Billion | USA | $144.34 | +1.55% | +4.53% | 18.21 Million |
| 89 |
Travere Therapeutics Inc
NASDAQ:TVTX |
$4.77 Billion | $4.77 Billion | USA | $50.57 | -0.54% | -3.82% | 47.44 Million |
| 90 |
Dianthus Therapeutics Inc.
NASDAQ:DNTH |
$4.63 Billion | $4.63 Billion | USA | $82.70 | +0.47% | +5.89% | 22.24 Million |
| 91 |
3SBio Inc
F:83B |
$4.58 Billion | €3.92 Billion | Germany | €1.57 | +1.64% | -0.92% | 1.15K |
| 92 |
Amicus Therapeutics Inc
NASDAQ:FOLD |
$4.55 Billion | $4.55 Billion | USA | $14.49 | +0.00% | +0.21% | 59.70 Million |
| 93 |
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252 |
$4.53 Billion | CN¥30.99 Billion | China | CN¥4.70 | -0.21% | -3.09% | 1.17 Billion |
| 94 |
Chongqing Zhifei Bio Products
SHE:300122 |
$4.51 Billion | CN¥30.83 Billion | China | CN¥12.88 | -0.85% | +1.10% | 627.33 Million |
| 95 |
Scholar Rock Holding Corp
NASDAQ:SRRK |
$4.51 Billion | $4.51 Billion | USA | $44.18 | +2.15% | +2.74% | 42.22 Million |
| 96 |
Akero Therapeutics Inc
NASDAQ:AKRO |
$4.50 Billion | $4.50 Billion | USA | $54.65 | +0.00% | +0.39% | 64.49 Million |
| 97 |
Camurus AB
ST:CAMX |
$4.30 Billion | Skr39.96 Billion | Sweden | Skr670.00 | +0.00% | +0.00% | 1.96 Million |
| 98 |
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SHG:603392 |
$4.29 Billion | CN¥29.30 Billion | China | CN¥23.17 | -2.65% | -10.19% | 149.53 Million |
| 99 |
Sk Biopharmaceuticals Co Ltd
KO:326030 |
$4.13 Billion | ₩6.09 Trillion | Korea | ₩77800.00 | +3.46% | +3.73% | 2.63 Million |
| 100 |
Metsera, Inc. Common Stock
NASDAQ:MTSR |
$4.12 Billion | $4.12 Billion | USA | $70.50 | +0.00% | -13.55% | 79.04 Million |
| 101 |
Legend Biotech Corp
NASDAQ:LEGN |
$3.99 Billion | $3.99 Billion | USA | $22.30 | -1.02% | +19.70% | 48.59 Million |
| 102 |
Veradermics, Incorporated
NYSE:MANE |
$3.94 Billion | $3.94 Billion | USA | $143.85 | +0.01% | +5.26% | 19.08 Million |
| 103 |
Catalyst Pharmaceuticals Inc
NASDAQ:CPRX |
$3.85 Billion | $3.85 Billion | USA | $31.49 | +0.00% | +0.06% | 53.87 Million |
| 104 |
Tango Therapeutics Inc
NASDAQ:TNGX |
$3.80 Billion | $3.80 Billion | USA | $22.53 | +1.35% | -16.49% | 104.83 Million |
| 105 |
Edgewise Therapeutics Inc
NASDAQ:EWTX |
$3.66 Billion | $3.66 Billion | USA | $38.91 | -3.90% | -1.87% | 33.02 Million |
| 106 |
Beijing Tiantan Biological Products Corp Ltd
SHG:600161 |
$3.58 Billion | CN¥24.46 Billion | China | CN¥12.37 | -1.75% | +1.14% | 298.76 Million |
| 107 |
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD |
$3.58 Billion | $3.58 Billion | USA | $20.76 | +2.17% | +2.82% | 45.62 Million |
| 108 |
HLB Co. Ltd
KQ:028300 |
$3.57 Billion | ₩5.28 Trillion | Korea | ₩39700.00 | -2.34% | -6.26% | 26.72 Million |
| 109 |
SpringWorks Therapeutics Inc
NASDAQ:SWTX |
$3.54 Billion | $3.54 Billion | USA | $46.99 | +0.00% | +0.00% | 5.01 Million |
| 110 |
Abcellera Biologics Inc
NASDAQ:ABCL |
$3.53 Billion | $3.53 Billion | USA | $13.08 | -4.11% | +6.86% | 116.93 Million |
| 111 |
Parabilis Medicines, Inc. Common Stock
NASDAQ:PBLS |
$3.47 Billion | $3.47 Billion | USA | $28.70 | +1.88% | +3.05% | 26.81 Million |
| 112 |
Viking Therapeutics Inc
NASDAQ:VKTX |
$3.42 Billion | $3.42 Billion | USA | $26.86 | +5.91% | +1.82% | 132.85 Million |
| 113 |
Genscript Biotech Corporation
F:G51 |
$3.36 Billion | €2.88 Billion | Germany | €4.26 | +3.40% | +12.70% | 1.20K |
| 114 |
Shanghai Junshi Biosciences Co Ltd
SHG:688180 |
$3.34 Billion | CN¥22.84 Billion | China | CN¥29.84 | -1.81% | -3.93% | 288.87 Million |
| 115 |
Enliven Therapeutics Inc.
NASDAQ:ELVN |
$3.30 Billion | $3.30 Billion | USA | $45.08 | +0.67% | +7.80% | 36.30 Million |
| 116 |
Suzhou Zelgen Biopharmaceuticals Co Ltd
SHG:688266 |
$3.26 Billion | CN¥22.29 Billion | China | CN¥84.20 | -6.43% | -17.90% | 86.07 Million |
| 117 |
Tarsus Pharmaceuticals Inc
NASDAQ:TARS |
$3.26 Billion | $3.26 Billion | USA | $74.20 | +2.98% | +5.25% | 19.54 Million |
| 118 |
Celcuity LLC
NASDAQ:CELC |
$3.21 Billion | $3.21 Billion | USA | $69.30 | -0.23% | +12.57% | 40.75 Million |
| 119 |
Hualan Biological EngineeringInc
SHE:002007 |
$3.21 Billion | CN¥21.91 Billion | China | CN¥11.99 | -2.04% | -7.70% | 250.07 Million |
| 120 |
TELIX Pharmaceuticals Ltd
AU:TLX |
$3.19 Billion | AU$4.51 Billion | Australia | AU$13.48 | +3.22% | -7.16% | 51.54 Million |
| 121 |
Ideaya Biosciences Inc
NASDAQ:IDYA |
$3.17 Billion | $3.17 Billion | USA | $32.89 | -3.15% | -7.27% | 20.86 Million |
| 122 |
ABCELLERA BIOLOGICS
F:8QQ |
$3.15 Billion | €2.69 Billion | Germany | €11.76 | +0.17% | +13.73% | 10.51K |
| 123 |
Denali Therapeutics Inc
NASDAQ:DNLI |
$3.09 Billion | $3.09 Billion | USA | $19.32 | +0.16% | +3.43% | 42.74 Million |
| 124 |
Arcutis Biotherapeutics Inc
NASDAQ:ARQT |
$3.07 Billion | $3.07 Billion | USA | $31.97 | +1.65% | +0.31% | 54.62 Million |
| 125 |
Bavarian Nordic
CO:BAVA |
$2.97 Billion | Dkr18.99 Billion | Denmark | Dkr247.80 | -3.05% | +1.64% | 5.17 Million |
| 126 |
Relay Therapeutics Inc
NASDAQ:RLAY |
$2.95 Billion | $2.95 Billion | USA | $19.47 | -1.12% | +5.76% | 58.80 Million |
| 127 |
Xenon Pharmaceuticals Inc
NASDAQ:XENE |
$2.90 Billion | $2.90 Billion | USA | $37.54 | +3.30% | +4.42% | 39.99 Million |
| 128 |
BB Biotech AG
SW:BION |
$2.90 Billion | CHF2.29 Billion | Switzerland | CHF51.20 | +1.99% | +1.59% | 1.97 Million |
| 129 |
Dyne Therapeutics Inc
NASDAQ:DYN |
$2.82 Billion | $2.82 Billion | USA | $17.04 | +0.35% | +6.04% | 71.51 Million |
| 130 |
Soleno Therapeutics Inc
NASDAQ:SLNO |
$2.76 Billion | $2.76 Billion | USA | $53.01 | +0.00% | +0.11% | 48.81 Million |
| 131 |
Disc Medicine Inc.
NASDAQ:IRON |
$2.69 Billion | $2.69 Billion | USA | $82.84 | -0.43% | +9.00% | 33.70 Million |
| 132 |
ATAI Life Sciences BV
NASDAQ:ATAI |
$2.69 Billion | $2.69 Billion | USA | $7.35 | +0.00% | +0.00% | 286.56 Million |
| 133 |
Xiamen Amoytop Biotech Co Ltd
SHG:688278 |
$2.62 Billion | CN¥17.88 Billion | China | CN¥43.80 | -0.95% | -6.35% | 68.64 Million |
| 134 |
Beam Therapeutics Inc
NASDAQ:BEAM |
$2.60 Billion | $2.60 Billion | USA | $28.84 | +0.21% | +16.10% | 45.03 Million |
| 135 |
KEYMED BIOSCIENCES -0001
F:64Z |
$2.59 Billion | €2.22 Billion | Germany | €7.60 | +1.33% | -20.83% | 1.33K |
| 136 |
Hebei Changshan Biochem Pharma
SHE:300255 |
$2.56 Billion | CN¥17.52 Billion | China | CN¥19.06 | -1.40% | -4.80% | 432.44 Million |
| 137 |
Zealand Pharma A/S
CO:ZEAL |
$2.56 Billion | Dkr16.34 Billion | Denmark | Dkr232.00 | +1.22% | +0.13% | 9.62 Million |
| 138 |
BioArctic AB (publ)
ST:BIOA-B |
$2.56 Billion | Skr23.75 Billion | Sweden | Skr319.40 | -0.25% | +6.04% | 2.63 Million |
| 139 |
Zai Lab Ltd
NASDAQ:ZLAB |
$2.51 Billion | $2.51 Billion | USA | $22.36 | -2.95% | -7.60% | 24.03 Million |
| 140 |
Adaptive Biotechnologies Corp
NASDAQ:ADPT |
$2.43 Billion | $2.43 Billion | USA | $28.17 | -0.70% | +11.21% | 50.03 Million |
| 141 |
Precigen Inc
NASDAQ:PGEN |
$2.38 Billion | $2.38 Billion | USA | $6.64 | +9.21% | +0.61% | 119.75 Million |
| 142 |
Pharvaris BV
NASDAQ:PHVS |
$2.36 Billion | $2.36 Billion | USA | $33.58 | +2.32% | +9.52% | 15.38 Million |
| 143 |
NewAmsterdam Pharma Company N.V. Ordinary Shares
NASDAQ:NAMS |
$2.35 Billion | $2.35 Billion | USA | $20.76 | -1.47% | -3.40% | 35.20 Million |
| 144 |
Celldex Therapeutics Inc
NASDAQ:CLDX |
$2.35 Billion | $2.35 Billion | USA | $29.89 | +0.78% | +1.77% | 33.58 Million |
| 145 |
Arcus Biosciences Inc
NYSE:RCUS |
$2.34 Billion | $2.34 Billion | USA | $18.61 | +1.20% | -2.57% | 56.02 Million |
| 146 |
SOLENO THERAPEUT. DL-001
F:6XC |
$2.31 Billion | €1.97 Billion | Germany | €44.86 | +1.70% | +1.20% | 130.00 |
| 147 |
Harmony Biosciences Holdings
NASDAQ:HRMY |
$2.25 Billion | $2.25 Billion | USA | $38.59 | +0.23% | +0.73% | 24.30 Million |
| 148 |
Biohaven Ltd.
NYSE:BHVN |
$2.21 Billion | $2.21 Billion | USA | $16.49 | +6.25% | +40.34% | 79.37 Million |
| 149 |
89bio Inc
NASDAQ:ETNB |
$2.20 Billion | $2.20 Billion | USA | $14.84 | +0.00% | +0.00% | 0.00 |
| 150 |
Vera Therapeutics Inc
NASDAQ:VERA |
$2.19 Billion | $2.19 Billion | USA | $30.53 | -1.33% | -2.15% | 40.89 Million |
How Biotechnology Companies Are Ranked by Market Cap
Biotechnology companies are ranked by market cap, the latest share price multiplied by shares outstanding, with each company counted once at its primary listing.
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries